author-photo

Caroline Peyrode

French Institute of Health and Medical Research

23

Papers

107

Citations

Citation Trend

Filter By

Papers (17) Sort By

Journal Conference Others

Design, synthesis and evaluation of targeted hypoxia-activated prodrugs applied to chondrosarcoma chemotherapy.

2020 Bioorganic Chemistry
Show All
- Source
- Cite
- Save
Citations (1)
Answer to Grzelecki et al, Joint Bone Spine 2020, doi:10.1016/j.jbspin.2020.04.022.

2020 Joint Bone Spine
Show All
- Source
- Cite
- Save
Citations (0)
Interest of in vivo CEST MRI to study chondrosarcoma tumour microenvironment

2019
Show All
- Source
- Cite
- Save
Citations (0)
Comparison of several biomarkers (MMP-2, MMP-9, the MMP-9 inhibitor TIMP-1, CTX-II, calprotectin, and COMP) in the synovial fluid and serum of patients with and without septic arthritis

2019 Joint Bone Spine
Show All
- Source
- Cite
- Save
Citations (6)
Comparaison de plusieurs biomarqueurs dans le liquide synovial et le sérum de patients ayant une arthrite septique ou une arthrite d’une autre étiologie

2019 Revue du Rhumatisme
Show All
- Source
- Cite
- Save
Citations (0)
Structure-activity relationship study of hypoxia-activated prodrugs for proteoglycan-targeted chemotherapy in chondrosarcoma

2018 European Journal of Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (5)
CEST MRI to contrast chondrosarcoma tumors: two contrasts in one acquisition

2018
Show All
- Source
- Cite
- Save
Citations (0)
Targeted hypoxia-activated phosphoramide mustards toward tumor proteoglycans in chondrosarcoma

2018
Show All
- Source
- Cite
- Save
Citations (0)
Proteoglycan-targeting applied to hypoxia-activated prodrug therapy in chondrosarcoma: first proof-of-concept

2017 Oncotarget
Show All
- Source
- Cite
- Save
Citations (8)
Proteoglycans as Target for an Innovative Therapeutic Approach in Chondrosarcoma: Preclinical Proof of Concept

2016 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (8)